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Multiplex ampliﬁable probe hybridizationGenome structural variation shows remarkable complexity with respect to copy number, sequence content
and distribution. While the discovery of copy number polymorphisms (CNP) has increased exponentially
in recent years, the transition from discovery to genotyping has proved challenging, particularly for CNPs em-
bedded in complex regions of the genome. CNPs that are collectively common in the population and possess a
dynamic range of copy numbers have proved the most difﬁcult to genotype in association studies. This is in
some part due to technical limitations of genotyping assays and the sequence properties of the genomic
region being analyzed. Here we describe in detail the basis of a number of molecular techniques used to
genotype complex CNPs, compare and contrast these approaches for determination of multi-allelic copy
number, and discuss the potential application of these techniques in genetic studies.
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rights reserved.1. Introduction
The human genome contains several levels of genetic variation,
from single base changes to those affecting entire chromosomes.
Copy number variants (CNVs) now operationally deﬁned as deletions
87S. Cantsilieris et al. / Genomics 101 (2013) 86–93and duplications >50 bp, can be rare (b1%) or common (>5%), large
(>1Mp) or small (b500 bp), and di-allelic (0–3) or multi-allelic (>3
diploid copy numbers) [1]. CNVs that segregate at appreciable fre-
quency in the population are termed copy number polymorphisms
(CNPs), and those that show a dynamic range of diploid copy number
(multi-allelic) will be the focus of this review. Multi-allelic CNPs are
attractive candidates for disease association studies for several
reasons. Many of these CNPs contain genes, and these genes appear
to be over-represented in pathways associated with immunity and
interaction with the environment [2]. Furthermore, there is evidence
of stratiﬁcation in human populations, indicating that such regions
are positively selected and are of clinical relevance [3]. Finally, gene
duplication followed by adaptive evolution can facilitate new gene
function, resulting in changes of phenotype [4].
Several techniques have been described to measure CNVs in the
human genome, however, with such diverse genetic properties, no
single existing methodology has the scope for accurately genotyping
all CNV classes. The dynamic range that exists within complex CNPs
poses signiﬁcant challenges for accurate genotyping. In principle, this
likely reﬂects the greater quantitative differences when detecting
deletion copy numbers compared to duplications or multi-allelic loci.
Distinguishing four from ﬁve diploid copy numbers reproducibly, com-
pared to that of one and two, is difﬁcult using standard methodologies
[5]. This clearly poses problems for genotyping in association studies.
Such observations have highlighted the substantial ascertainment
bias towards the detection of deletion variants from high resolution
genome wide studies (77%) [6], and the limitations of certain tech-
niques for assessing these regions [7]. This is further complicated by
the fact that CNVs are enriched (10-fold) for segmental duplications
(SDs, deﬁned as sequences >95% and >1 kb in length) making charac-
terization of these regions difﬁcult using current methodologies [8].
Whole Genome Sequencing (WGS) in combination with sequence
read depth, allows the analysis of many complex regions of the genome
thatwere excluded from conventional genomewide association studies
(GWAS) [9]. Seminal work by Sudmant et al. identiﬁed nearly 1000
genes within these regions, ranging from 0 to 48 copies at 3 kb resolu-
tion. Such a result expands our knowledge of the “assayable” portion of
the genome, but indicates that many highly duplicated regions are yet
to be analyzed in studies of disease. It has also been demonstrated
that a signiﬁcant proportion of CNPs residing in SD's are not in Linkage
Disequilibrium (LD) with nearby single nucleotide polymorphisms
(SNPs) [8]. A study of 192 CNPs, showed that only 40% of those located
in SDs had high correlation to nearby SNPs, in comparison to 70% of 892
CNPs in unique regions of the genome [8]. These ﬁndings illustrate thatTable 1
Methods to measure complex copy number polymorphisms.
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a High resolution Array CGH can achieve a minimum resolution of >500 bp6.
b Minimum resolution is in general the length of a single probe.for a large number of CNPs, genotypes cannot be imputed through the
use of tagSNPs and must be measured directly.
There is continued interest in assessing the relevance of multi-allelic
CNPs in complex disease, however, in some cases technical difﬁculties
have impeded the reproducibility of these associations [7,10]. In
addition, techniques amenable to genotyping in large scale studies can
suffer from poor resolution particularly assignment of integer copy
number, meaning that a compromisemust be reached between accura-
cy and cost (Table 1). In general the most accurate techniques are the
most labor intensive. Given that large numbers of individuals are re-
quired for robust associations and batch effects have the potential to
create bias in genotyping, it is necessary to understand the strengths
and limitations of methodologies used to analyze multi-allelic CNPs.
1.1. Hybridization-based techniques
1.1.1. Fiber FISH
Fluorescence in-situ hybridization (FISH) is a visual technique, typi-
cally used to identify chromosomal abnormalities from metaphase or
interphase spreads using ﬂuorescent probes. The strength of FISH lies
in the direct visualization of DNA copy number at the single cell level.
Multi-allelic CNPs, however, can be more difﬁcult to analyze, especially
when attempting to resolve tandem duplications. Amodiﬁed approach,
known as Fiber FISH, possesses sufﬁcient resolving power to analyze
complex structural rearrangements. The principle of this technique
involves the release and ﬁxation of DNAmolecules from interphase nu-
clei onto a slide, with the DNA stretched in a linear fashion throughme-
chanical or gravitational force [11]. The DNA ﬁbers can be hybridized
with ﬂuorochrome-labeled DNA probes, producing a characteristic
“beads on a string” pattern which is easily distinguishable from back-
ground probe signals [12]. Visualization of multiple DNA targets can
be achieved using multi-colored probes, which appear as barcode-like
signal patterns in the presence of tandem duplications [12]. Simple
and complex genomic rearrangements, as well as repetitive sequences,
can be accurately resolved using Fiber FISH. A striking example of the
ability to resolve complex multi-copy gene re-arrangements was dem-
onstrated in a study of the salivary amylase (AMY1) gene [13]. Individ-
uals with tandem duplications of >10 copies could be accurately
resolved using Fiber FISH. Techniques which measure changes in dip-
loid dosage have the potential to miss assign complex copy numbers
as de-novo events in the offspring, purely due to the number of different
combinations and inheritance patterns [2]. A key advantage to using
Fiber FISH, is that it allows the determination of CN per allele which is
important for studies of inheritance and disease [13]. Limitations ofAPHb MLPAb PRTb SNP array Array CGHa NGS
ange
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high quality sample requirement. In addition, highly variable regions
are difﬁcult to interpret if there are overlapping signals. However, this
remains the most accurate methodology for typing multi-allelic CNPs.
1.1.2. Southern blotting and Pulsed Field Gel Electrophoresis
Southern blotting is a powerful method for typing structural
rearrangements. The principle of the technique relies upon fragmen-
tation of DNA with a restriction endonuclease enzyme, followed by
gel electrophoresis and transfer to a nylon membrane (blotting)
[14]. Hybridization using a labeled DNA probe and exposure to ﬁlm
allows visualization of target regions [14]. As this technique encom-
passes both hybridization and electrophoresis steps, detection of
structural rearrangements occurs through comparison of hybridiza-
tion intensities between a normal control and unknown samples
[15] and/or the creation of altered fragment sizes (Fig. 1).
Complex CNPs can be resolved using Southern Blot Hybridization.
For example, it has been shown that Southern blot analysis can resolve
copy number at the FCGR3B locus (commonly exists between 1 and 4
copies per diploid genome), through differential band intensities after
normalization on a reference locus, with decreased or increased ratio
indicative of CNV [16]. Disadvantages to this technique include labor
intensive workﬂow and the requirement for large amounts of high
quality genomic DNA. A particularly important caveat is that uneven
transfer of DNA to the nylon membrane or incomplete washing of
probes can result in misinterpretation of band intensities. Careful con-
sideration of probe design and choosing restriction enzymes that create
distinguishable length differences between fragments, can minimize
the impact of this limitation.
Hybridization intensity alone is not ideal for determination of com-
plex CNPs, as intensity differences can be subtle and copy numbers can
potentially be mis-scored. Pulsed ﬁeld gel electrophoresis (PFGE) in
combination with Southern Blotting, is a powerful technique with re-
spect to resolution (ability to resolve DNA sequences >12 Mb) and ac-
curacy for measuring copy number (analysis of altered junction
fragments) [17]. PFGE is useful for both restrictionmapping and charac-
terizing large genomic re-arrangements [18]. A limitation of conven-
tional agarose gel techniques is that size resolution is dependent on
migration of DNA molecules through a relatively small gel pore. Large
DNA molecules which exist as random coils, must unravel to enable
electrophoresis through a much smaller gel matrix [17]. This leads to
size independent mobility and loss of resolution. To circumvent this
limitation, PFGE includes periodic alteration of the electric ﬁeld whichFig. 1. Schematic showing the detection of copy number changes through the use of dif-
ferential band intensities (Southern Blot) and altered junction fragments (Pulse Field
Gel Electrophoresis). A)Gene dosage effects are clearly visible as differential hybridization
intensities. Deletions bands are approximately half as intense as control bands, whilst du-
plications bands are 50%more intense than control bands. B) Copy number changes clear-
ly visible as altered fragment sizes differentiated by length. Combining allele information
allows inference of total gene copy number.produces continuous re-orientation of DNA molecules. This allows the
resolution of large DNA fragments. The utility of this technique in the
detection of chromosomal re-arrangements extends not only to dele-
tions and duplications but also translocations, insertions and inversions
which are difﬁcult to detect by other methods beyond PFGE and FISH
[15].
PFGE is useful for inferring absolute copy number of multi-allelic
CNPs, as the presence of additional fragments corresponding to length
differences of the repeat structure is a more accurate measure of the
number of gene copies in comparison to intensity differences. For
example, a study of the Fcγ receptors by Hollox et al. demonstrated
that estimated copy numbers of 3, 4 and 5 by paralogue ratio test
corresponded to additional fragments sizing at increasing 84 kb inter-
vals, matching the length of the duplicon containing the Fcγ region
[19]. Further work by Aldred et al., determined absolute copy number
using PFGE on two α defensin genes, DEFA1 and DEFA3 [20]. DEFA1
andDEFA3 range between four and eleven copies in the general popula-
tion, and Hpa I restriction fragments resulted in different length alleles
corresponding to three, four and ﬁve copies of both genes [20]. A key
advantage of PFGE is that all types of rearrangements are detectable
as altered junction fragment sizes, thus comparison of hybridization in-
tensities is not required. Limitations include the labor intensive
workﬂow, the requirement of highmolecular weight DNA that is not al-
ways available from archived samples, and the characterization of
rearrangements being restriction enzyme site dependent.1.3. PCR techniques
1.3.1. Quantitative PCR
Quantitative PCR is a high throughput technique for determining
gene copy number. The basic principle behind qPCR is the measure-
ment of PCR amplicon accumulation in real time. The fractional
cycle number (Ct) is proportional to the amount of starting template,
when the ampliﬁcation during the exponential phase of the reaction
reaches a deﬁned threshold [21]. Amplicon accumulation is measured
by ﬂuorescent based chemistry, which primarily consists of either
DNA intercalating dyes such as SYBER green or probe based method-
ologies such as TaqMan®, Scorpion and molecular beacons. The most
popular approach is the TaqMan® primer and probe chemistry sup-
plied by Applied Biosystems, which incorporates a duplex real time
reaction for the gene of interest (GOI) and a reference gene (RG)
(generally RNase P) for normalization. Data analysis is conducted
using the comparative Ct method (ΔΔCt) where the Ct values of the
GOI and RG are compared between a control sample and an
unknown, with the equation presented as 2−ΔΔCt [22]. CopyCaller™
software automatically calculates the equation presenting the pre-
dicted copy number and conﬁdence in the call. An underlying re-
quirement for using the ΔΔCt method is that the PCR ampliﬁcation
efﬁciencies for both the GOI and RG, should be similar as there is no
correction for the difference in efﬁciencies in the equation [22]. An-
other commonly used approach to convert raw Ct values into normal-
ized relative quantities is the standard curve method, which is used to
calculate both PCR efﬁciency and interpret samples of unknown
quantity [23]. Absolute or relative quantitation of an unknown sam-
ple can be achieved using a standard curve, which is constructed by
amplifying known amounts of target DNA (usually a serial dilution),
plotting the resultant Ct values as log concentrations and ﬁtting a lin-
ear trend line to the data [23]. Either methodology is in principle suit-
able for analyzing CNP data. Studies of the CCL3L1 gene, known to
exist from 0 to 10 copies per diploid genome have been estimated
using standard curve methodology [24]. Copy number was calculated
by converting the Ct value into template quantity using the standard
curve and determining the ratio of CCL3L1 template quantity to refer-
ence gene β globin multiplied by 2. The copy number value was
rounded to the nearest copy number integer [24].
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ies, with the advantages of simple workﬂow procedure (3–4 h from
sample preparation to result), high throughput capabilities and cost ef-
fectiveness in typing large sample numbers, and requiring relatively
small amounts of DNA in comparison to many other methodologies
for detecting CNVs (Table 1). Despite these advantages, there are signif-
icant limitations regarding the use of qPCR in genotyping multi-allelic
CNPs. Several studies comparing Paralogue Ratio Test (PRT) and qPCR
have found that, results gained byqPCR can be inﬂuenced bydifferential
sample preparation, storage conditions and DNA degradation [7,25]. In
addition, it has been shown that qPCR can generate results where
there is extensive overlap between copy number integer classes
[7,25]. Such a result would have dramatic affects on association studies.
It is also worth noting that a study directly comparing qPCR and Multi-
plex Ligation-dependent Probe Ampliﬁcation (MLPA) for analysis of
beta-defensin yielded markedly different results using qPCR, often
mis-scoring CN by several copies [26]. The effects observed by direct
comparison between qPCR and other well established techniques
have important implications for large scale association studies. It is
clear that “Binned” or rounded data to the nearest integer, can result
in spurious associations. The inability of qPCR to multiplex more than
one locus for CNV analysis means that multiple measurements cannot
be performed simultaneously, therefore many replicates maybe re-
quired to reach a consensus result.
1.3.2. Multiplex ampliﬁable probe hybridization (MAPH)
MAPH, ﬁrst described by Armour and colleagues in 2000, is a tech-
nique based on quantitative recovery of probes after hybridization to
immobilized DNA [27]. The amount of probe hybridization is propor-
tional to the relative copy number of the binding site in the genomic
DNA. MAPH probes were initially created by cloning small DNA frag-
ments into vectors [27]. A less laborious approach involves the use of
primer pairs containing identical 5′ sequences (MAPH sequences), to
amplify target sequences from genomic DNA followed by pooling into
a probe mix [28]. A limitation of this approach is that more than one
PCR product per target locus could potentially be ampliﬁed during the
creation of the probe mix, and as the probes have common ends,
these extra products will be carried over in the ampliﬁcation step [28].
The MAPH procedure utilizes genomic DNA immobilized to a nylon
ﬁlter, overnight probe hybridization followed by a washing step to
remove unbound probes. Bound probes are then released into solution
by heating, and an aliquot is used for PCR. The original MAPH
technique utilized radioactive labeling followed by polyacrylamide gel
electrophoresis to visualize the PCR amplicons [27]. This was subse-
quently replaced by ﬂuorescent labeling and separation by capillary
electrophoresis [28]. Probes can be normalized by dividing the peakFig. 2. Relative difference between integer copy number. The quantitative differences betwee
in integer copy number from 0–4 copies. The relative difference between each of the integers
copy number from 2–6 copies. A median copy number of 4 results in a relative difference o
achievable as experimental variability can result in extensive overlap of clusters obscuringheight (or area) of the probe by the heights of control peaks (loci
known to be present in two copies), dividing the height of each peak
by the sum of all peaks in a reaction, known as “global normalization”,
or by dividing the height of each peak by the sum of the four nearest
probes in a mix known as the “nearest neighbor approach” [28].
MAPH has several advantages compared to other techniques. As the
probe sequences are generally long (100–400 bp) and PCR is conducted
directly from hybridized probes, MAPH is not affected by unsuspected
polymorphisms under the probe binding sites. MAPH can generally
multiplex up to 40 loci making it a cost effective and accurate method
for typing many CNV loci simultaneously. Limitations include labor in-
tensive probe preparation, DNA needing to be ﬁxed to a membrane
for stringent washing, and the fact thatwithout a ligation step the spec-
iﬁcity of the probes is dependent on the sequence properties of the
genomic region.
MAPH has been shown to be effective for resolving several complex
CNVs such as the beta-defensin region, which commonly exists be-
tween 2 and 9 copies per diploid genome (although as many as 12
has been observed) [29]. The beta-defensin region has a median copy
number of four in European populations [25], and poses a considerable
challenge for accurate genotyping. Studies of European control pop-
ulations have shown that more than 80% of samples have 3–5 copies.
The relative difference between the median copy number of 4 normal-
ized to 1.0 is 0.75 for 3 copies and 1.25 for 5 copies. Distinguishing this
difference reproducibly requires measurement of a relative increase of
0.25, which is not easily achieved using standard methodologies
(Fig. 2) [5]. Multiple measurements indeed increase the precision of
copy number calls and previous studies of beta-defensin have taken
six independent MAPH measurements, calculated the average of each
probe and rounded the mean to the nearest integer copy number
[29,30]. When compared to other techniques such as FISH and PFGE
[29] this appears to yield accurate copy number estimations.
1.3.3. Multiplex ligation-dependent probe ampliﬁcation (MLPA)
MLPA is a versatile method for analyzing copy number variation at
multiple loci (>40) from relatively low amounts of genomic DNA
[31]. The technique relies upon hybridization and ligation of two
adjacently situated oligonucleotides to a speciﬁc genomic DNA se-
quence. As withMAPH, all probes have identical 5′ sequences, allowing
ampliﬁcationwith a single primer pair. Typically products are separated
on a capillary sequencer based on size, and the resultant ﬂuorescence
intensities are exported for further analysis [28]. The sensitivity of the
ligation step makes this method extremely powerful for analyzing se-
quences of high identity, by designing probeswithmismatches at the li-
gation site. It is effective for measuring SDs, as notionally a probe can
differentiate two sequences differing only by a single mismatch at then 1 and 2 copies is greater than that of 4 and 5 copies (A) and (B). A) Stepwise increase
is 0.5, consistent with an increase or decrease of 1 copy. B) Stepwise increase in integer
f 0.25 between each of the integer copies (blue clusters). In practice this is not always
accurate integer assignment (red clusters).
90 S. Cantsilieris et al. / Genomics 101 (2013) 86–93ligation site. One potential limitation is that sequence polymorphisms at
and around the ligation site can disturb ligation sufﬁciently to give the
appearance of an apparent mosaic deletion event (a limitation not
shared by MAPH) [32].
Essentially, MLPA is analyzed in the same manner as MAPH
(described above). Multi-allelic CNPs can be calculated by ordering
the normalized ratios from low to high and assigning copy number
integers deﬁned by eye in a cluster analysis. By plotting these values
in a scatter plot and calculating the relative differences between the
subgroups (0.5=1 copy, 1.0=2 copies, and 1.5=3 copies) an estima-
tion of DNA copy numbers can be performed (Fig. 2). For example, a
study by White et al. performed MLPA analysis on the NSF gene, and
was able to identify discrete copy number classes ranging from 2 to 7
copies with distinct differences between each of the subgroups [33].
This methodology has also been shown to be effective for the FCGR3B
region. In addition to analyzing the clusters by eye, however, Marques
et al. conﬁrmed the cluster analysis using a statistical approach that val-
idated the intensity ratios and cut-offs for assigning discrete copy num-
ber integers [34] Previous studies have also utilized the “nearest
neighbor approach” for analyzing beta-defensin, where each test
probe was normalized against the sum of ﬁve nearest neighbor refer-
ence peaks (CN of 2) [35]. An average of 10 beta-defensin test probes
plotted on a scatter plot demonstrated discrete steps corresponding to
a stepwise increase in copy number integers from 2 to 9 copies [35].
The strengths of MLPA lie in the number of loci that can be analyzed
in a single reaction, the speciﬁcity of the ligation step, the reliability and
accuracy of CNVmeasurement, and the relative low cost for conducting
large scale association studies. Multiple steps are required to complete
the MLPA procedure thus at several points there is the possibility for
errors to be introduced.
1.3.4. Paralogue ratio test: PRT
One copy deletions and duplications can be detected usingQuantita-
tive Multiplex PCRmethods, performed under semi quantitative condi-
tions. Application to more complex CNPs has not yet been assessed, but
presumably, the differential PCR ampliﬁcation properties of the test and
reference loci will impact the reliability of accurate copy number esti-
mation. To mitigate the impact of experimental variability, Armour et
al. reported the use of paralogue ratio test (PRT), a comparative PCR
method based on ampliﬁcation of dispersed repeat sequences [36].
The principle of this technique relies on careful primer design, in
which two nearly identical sequences (differing in size) can be ampli-
ﬁed using a single set of primers (a reference and test locus) [36]. The
PCR is performed under quantitative conditions (30 cycles), and size
differences are measured by capillary electrophoresis. Utilizing a two
color dye system, multiple peak area measurements from the same
sample can be compared to generate concordant data [37]. The ratio
of test and reference loci allows an inference of gene copy number.
This methodology is particularly suited for analysis of complex regions
of the genome such as SDs. Inter-chromosomal repeat sequences are
preferable as they are unlikely to be linked to the CNV locus. In recent
times this technique has been widely adopted for analyzing multi-
allelic CNPs including Beta-defensin, CCL3L1, FCGR3B and Complement
Component 4 (C4) [7,19,37,38]. This has proven to be an accuratemeth-
od of CNV detection [7,37]. One particular strength of PRT is that the
ﬁrst pass assignment of integer copy number is quite high at 85% for
CCL3L1, 93% for FCGR3B, 93% for the beta-defensin locus, and 91% for
C4 [19,36–38]. This is particularly useful for association studies as repeat
testing of 10% of samples is certainly within acceptable limits with re-
spect to cost and labor. PRT has been shown to be superior to qPCR in
terms of determining integer copy number and accuracy in copy num-
ber measurement >4 [7,25]. In addition, the workﬂow procedure is
quite rapid as it does not require the lengthy overnight hybridization
steps, that are components of both MLPA and MAPH. With respect to
cost, it is a relatively inexpensive means to determine copy number in
large scale association studies, and requires low quantities of genomicDNA (10–20 ng). Studies have shown comparable accuracy to other
well validated methods such as MLPA and MAPH [36]. Limitations to
this methodology relate to the fact that it is assumed that the
paralogous reference loci do not itself vary in copy number, that sites
of primer binding are free from polymorphisms that can affect primer
binding efﬁciency, and the dependence of identifying paralogous
sequences outside the target region. One technical limitation is that re-
gions of high sequence identity, such as FCGR3A/FCGR3B and C4A/C4Bdo
not contain the sequence differences required for primer speciﬁcity. To
circumvent this limitation both genes are ampliﬁed and cut using re-
striction enzymes, with a digestion time >4 h [19,38] Another draw-
back is a lower multiplexing capacity compared to techniques such as
MLPA and MAPH.
2. Array based approaches
2.1. Array CGH
Array CGH is a technique based on dual hybridization of test and ref-
erence DNA to either short or long oligonucleotides (and historically
bacterial artiﬁcial chromosomes (BACs)) immobilized on a glass slide
[39]. The signal ratio between test and reference sample is normalized
and used to infer copy number. Initial approaches using BAC clones
with a resolution between 100 and 200 kb provided important insights
into the landscape of structure variation in the human genome [40],
however, poor breakpoint resolution typically led to overestimation of
CNV size. Subsequent studies implementing long oligonucleotide arrays
have provided a more accurate picture of the CNV landscape, with im-
proved resolution between 0.5 and 2 kb [6,41].
2.2. SNP microarrays
SNP microarrays are also hybridization based and have the advan-
tage of analyzing both single nucleotide differences and in some cases
non-polymorphic copy number probes that are not restricted by
sequence properties of SNPs [41]. In comparison to Array CGH, SNP
microarrays analyze a single sample permicroarray and compare signal
intensities from a sample with clustered intensities from a set of refer-
ence samples, or the whole sample population to generate a log ratio
[41,42]. SNPmicroarrays generate two types ofﬂuorescent information;
the total ﬂuorescence gained from intensity of both alleles, and the alle-
lic ratio gained from the relative intensity of each allele. By plotting the
normalized intensity of each allele against one another, three types of
clusters should emerge corresponding to the AA, AB and BB genotypes.
Results indicative of a deletion can result in three additional clusters
corresponding to reduced intensity of homozygous alleles indicative
of a heterozygous deletion, or no signal (failure to cluster) at all indica-
tive of a homozygous event. The intensity of one allele as a proportion of
the total allele signal, can also be used as an additional measure to con-
ﬁrm the presence of CNPs (Fig. 3) [42,43]. For example the proportion of
the B allele should correspond to 0, 0.5 and 1.0 for genotypes AA, AB and
BB respectively [42,43]. In this case heterozygous deletions are indicat-
ed by the loss of heterozygosity such that the BAF is 0 or 1 for AA and BB
genotypes. Homozygous deletions result in no signal. More complex
CNVs can also be indicated by the loss of the one to one ratio of each al-
lele, such that there is a skew in BAF at heterozygous sites indicative of
an AAAB, BBBA or AABB genotype (reﬂective of 4 copies). This is useful
for accurately predicting CNPs of 0–4 diploid copy numbers.
2.3. Application of arrays to CNP genotyping
The success for resolving complex CNPs into discrete copy number
classes is typically dependent on the genetic properties of the CNP,
the probe density/performance and the normalization parameters
[6]. A particularly important point is that the number of probes on
an array does not necessarily translate into improved coverage or
Fig. 3. The Allelic Ratio or B allele Frequency (BAF) to infermulti-allelic copy number. The BAF calculates the proportion of the B allele from the total allele signal, thereby using allelic ratio
to infer gene copy number. For example the BAF for AA, AB and BB genotypes should be 0, 0.5 and 1.0 respectively. No signal is indicative of a homozygous deletion. One copy genotypes
resulting in complete loss of heterozygosity signal indicated by BAF clustering around BAF=0 (AA) and BAF=1.0 (BB). More complex copy numbers such as three and four copy number
genotypes can result in quite different BAF values, e.g. allelic ratios of 0.33/ 0.67 (ABB) and 0.25/ 0.75 (ABBB) respectively.
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Affymetrix and Illumina SNP arrays do not sufﬁciently cover regions
of genome complexity such as SDs [8,44]. In addition, a study by
Conrad et al. using customized tiling array CGH could only reliably
genotype 61% of CNPs that map to SDs [6]. In general, SDs show
higher levels of false positive and false negative call rates for both
SNP and Array CGH platforms in comparison to unique regions of
the genome [42,44]. However, both the Nimblegen and Agilent
array CGH platforms contain substantially more probes in SD regions
than do Affymetrix and Illumina SNP arrays [44]. Not surprisingly,
large studies using customized array CGH platforms have found that
duplications and multi-allelic loci are more difﬁcult to detect than de-
letion variants [6,45]. This may be at least partially explained by an
ascertainment bias for some commercial arrays towards deletion var-
iants [44]. In particular, it is important to note that for multi-allelic
CNPs, the choice of normalization algorithm impacts the resolution
of the data [45] and that each individual locus must be treated sepa-
rately to achieve the best results.
Numerous analytical algorithms have been described to analyze
data from microarray platforms. However, different algorithms often
provide marked differences in the both the number and reliability of
CNV calls [44,46]. Studies have recommended that merging calls from
multiple algorithms may improve sensitivity, in comparison to using
multiple algorithms to increase conﬁdence in CNV calling which can
result in substantial increases in false negative call rates [44]. In ad-
dition, it has been shown that software developed speciﬁcally for
the particular array performs better than software independent al-
gorithms. For example, algorithms such as Birdsuite developed spe-
ciﬁcally for the Affymetrix 6.0 platform performed better in a direct
comparison with platform-independent algorithms such as Nexus
Copy Number [44].
The main strength of microarray platforms is the ability to screen
CNVs on a genome-wide level at relatively low cost in large data sets,
an advantage yet to be equaled by next generation sequencing plat-
forms. In general, parameters for reliable genotyping are set at ﬁve
consecutive probes and a minimum size of 1 kb [44]. Typically, most
single channel array platforms lose sensitivity to detect variants
below 10 kb [47]. There are, however, several limitations. The ability
of commercial microarray platforms to resolve breakpoints and de-
tect smaller rearrangements is generally poor, and is dependent on
probe location and spacing (minimum 10 kb). No positional informa-
tion is obtained, meaning that structural rearrangements that do not
affect copy number (such as inversions and translocations) will not
be detected. Estimation of copy number is relative, and it is assumed
that the diploid copy number for a given region is two, which is not
always the case (particularly in regions of segmental duplication).
The reliability of Array CGH CNV calls is also heavily dependent on
how well characterized the reference sample is. For example, a loss
in the reference sample can be interpreted as a gain in the test sample
even though the test sample may have a diploid copy number of two.3. Sequencing based approaches
3.1. Next generation sequencing
The abundance of data generated from next generation sequencing
(NGS) platforms has provided a wealth of information relating to the
extent of structural variation in the human genome [48]. The applica-
tion of a single comprehensive bioinformatic approach has remained
elusive, due to the short read limitations of NGS technology. Several
methodologies have recently emerged that are amenable to detecting
speciﬁc types of structural variation, including split read methods,
paired endmapping, read depth methods and whole genome assembly
[49]. Of these computational approaches only read depth methods and
whole genome assembly are suitable for genotyping complex CNPs and
are discussed below.
3.2. Read depth methods
Read depth methodology is a useful measure for determining abso-
lute copy number as essentially, the number of sequencing reads that
map to a speciﬁc region is proportional to the number of copies that
the region is present in the genome [49]. This basis for read depth
methods assumes a Poisson distribution of sequencing reads, thus a re-
gion can be assumed to be deleted or duplicated if the region has fewer
or moremapped reads than expected. This technique has been success-
fully applied to complex genomic regions containing multi-allelic CNPs
[9]. Typically, smaller CNV events and those that contain high genomic
copy number require deeper sequence read depth (SRD) to achieve
accurate CNV measurement. Recent data by Hollox et al. found a recip-
rocal relationship between the size of the CNV, and the required SRD to
accurately distinguish four from ﬁve copies. Interestingly, while in-
creases in SRD initially improve the accuracy of CNV measurement
(up to 50x coverage), much deeper SRD is required to achieve the
same gains in resolution beyond this point [2]. One limitation of using
massively parallel short-read sequencing is the inability to uniquely
map short reads to regions such as SDs. Singly unique nucleotides
(SUNs) provide a unique identiﬁer within duplicated sequences and
have been successfully applied to complex regions of the genome [9].
Using a combination of SUNs and SRD, copy number can be measured
in most segmental duplications with short reads of >30 bp and b5×
read depth. The accuracy of read depth approaches for determination
of multi-allelic CNPs was supported by showing high correlation with
qPCR and Array CGH experiments [9].
SRD approaches have recently been applied to exome sequencing
data. [50]. A challenging aspect of this analysis is that, in comparison
to whole genome sequence, exome sequence coverage is non-uniform
and can bebiased by factors such as sequence capture design. Encourag-
ingly, analysis of three or more exons could estimate absolute copy
number of multi-allelic genes with an accuracy of 78% with an en-
hanced ability to detected smaller CNVs >14 kb [50]. However, there
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which essentially target unique regions of the genome, pseudogenes
can obscure accurate copy number prediction due to extensive se-
quence homology, normalization of the X chromosomemeans the algo-
rithm is unsuitable for chromosome aneuploidy and discovery of novel
polymorphic CNPs is less sensitive in comparison to genotyping known
CNP regions.
An advantage in performing SRD analysis is being able to transform
relative copy number obtained from array CGH data into absolute copy
number [8,9,48]. Comparing absolute copy number predictions based
on SRD, with data generated by SNP or Array CGH allows integer copy
number to be calibrated and adjusted. A limitation of using intensity
data is that inferred integer copy number is prone to inaccuracy, espe-
cially at high copy number counts. Campbell et al. was able to correct
a number of regions that were discordant by one integer copy using
SRD which gave an accurate assessment of baseline copy number [8].
This will have important implications for future disease association
studies as we move from associating traits with a deviation from the
population median copy number (low or high) to assessing individual
integer copy number in a population.
3.3. Whole genome sequence assembly
Complete genome assembly compared to a high quality reference
genome is currently the most accurate way for discovering structural
variation. De novo assembly using NGS technology from a small num-
ber of genomes has already yielded between 5 and 50 Mb of novel se-
quence not identiﬁed in the NCBI reference assembly build 36 [51,52].
Analysis of 185 human genomes (as part of the 1000 genomes pro-
ject) compared three sequence-based computational approaches
(split read, paired end mapping and read depth) and found differ-
ences between the methods in terms of genomic regions ascertained,
accessible structural variation size range and breakpoint precision
[53]. Of the methodologies, read depth analysis and paired end map-
ping proved to be the most sensitive, and a newly developed method
((Genome STRiP) which integrates both approaches) proved to be the
most accurate [53].
The strength of NGS technology lies in the ability to identify many
different levels of genetic variation, from SNPs to small indels and
large CNVs. Recent advances in computational approaches allow accu-
rate estimation of multi-allelic CNPs that cannot be determined using
conventional capillary sequencing. In addition, the ability to identify
and characterize CNV break points will ultimately lead to a comprehen-
sive map of CNVs in the human genome. Despite the obvious advan-
tages in using NGS technology, there are several limitations. The
major issue is that no currently available computational approaches
are comprehensive. Both split read and paired endmapping approaches
are unreliable in duplicated regions of the genome, and read depth
method is poor at characterizing CNV breakpoints. In addition, algo-
rithms to assist in de novo assembly will require further improvement
before they can accurately map complex regions of the genome. The
quest for the perfect reference genome, (which may never be possible)
is further complicated by genes embedded in repeat rich regions such as
SDs, and such regions are incomplete even in the latest genome refer-
ence build [2]. For instance, a recent study by Alkan et al. found that
two recent de novo assemblies were 16.2% shorter than the reference
genome, with several Mb of missing sequences, including a large pro-
portion of repeat and duplicated sequence [54]. An integrated approach
using longer read technologies and new assembly algorithms will sub-
stantially improve the standard of de novo assembly, especially in com-
plex regions of the genome.
4. Future directions
Multi-allelic CNPs will contribute to a proportion of relative risk in a
variety of human complex diseases, although the signiﬁcance is likely tobe dependent on ethnicity, clinical phenotype and interaction with
other genomic loci. Accurate detection and measurement of multi-allelic
CNPs including direct assessment of integer copy number, in large ethni-
callymatched cohorts is required to fully understand their contribution to
complex disease.Wehave described the advantages and disadvantages of
a number of commonly usedmethodologies to assess complex CNPs. It is
clear from this that no single method is yet, suitable for all types of anal-
ysis. It is noteworthy that in combination, these techniques can be much
more powerful with respect to resolution and accuracy. For example, in-
tensity data from single channel array CGH combined with SRD analysis
can be used to calibrate multi-integer copy estimates [9]. Although Fiber
FISH, Southern blotting and PFGE are low throughput methodologies,
they are useful for accurately characterizing copy number reference sam-
ples to be used for downstream genotyping applications [38]. Conﬁrming
copy number estimates using two of the four PCR based methodologies
(MLPA,MAPH, QPCR and PRT) can allowan estimate to bemade of the re-
liability of the copy number typing [55]. The introduction of NGS technol-
ogy, and the development of improved computational approaches such as
read depth mapping using SUNs, have vastly improved the accuracy of
determining absolute copy number of multi-allelic CNPs. Finally, the im-
plementation of single cell sequencing will provide allele and inheritance
information, which is currently not achieved for any CNV methodology,
with the exception of Fiber FISH. Recent work in breast cancer tumors
has demonstrated that high resolution copy number proﬁles can be
achieved by ﬂow sorting, whole genome ampliﬁcation (WGA) and mas-
sively parallel sequencing [56]. The cost of performing WGS in large dis-
ease cohorts is not yet achievable for the average researcher. Targeted,
cost effective and high throughput techniques such as PRT, MLPA,
MAPH and qPCR will continue to be used for CNV genotyping in the
near future.
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